Events

InCarda at Biotech Industry Organization’s (BIO) International Conference 2019

June 3-6, 2019 - Philadelphia, PA “Addressing Unmet Need in Cardiovascular Disease” Panel At the 2019 Biotech Industry Organization’s (BIO) International Conference held in June in Philadelphia, InCarda’s CEO, Dr. Grace Colon, was a participant on a panel of distinguished experts entitled “Addressing Unmet Need in Cardiovascular...

InCarda at 2019 Stanford Biodesign New Arrhythmia Technologies Retreat

May 7, 2019 - Palo Alto, CA At the 2019 Stanford Biodesign New Arrhythmia Technologies Retreat, InCarda’s Chief Medical Officer, Dr. Luiz Belardinelli, provided an overview of the pre-clinical and clinical development for InRhythm (flecainide for inhalation). Dr. Bellardinelli explained to the audience of cardiology experts...

InCarda at Drug Delivery West

May 6-7, 2019 - San Diego, CA “A drug delivery 2.0 conference addressing the emerging needs for best routes of delivery” - Carlos Schuler, InCarda COO, CTO and Co-founder presented at the recent Drug Delivery West conference.      ...

InCarda at Sachs Associates Forum

February 25, 2019 - Zurich At the Sachs Associates Forum in Zurich, InCarda’s Dr. Grace Colón presented a company update to investors where she discussed the clinical challenges of atrial fibrillation and InCarda’s novel approach to treating it called, InRhythm (oral flecainide for inhalation). Sachs Associates is...

InCarda at BIO CEO & Investor Conference

February 11, 2019 - New York, NY At the BIO CEO and Investor Conference, Dr. Grace Colón was a panelist for a discussion on “Attacking Biological Mechanisms of Aging to Extend Healthspan” where she discussed a range of topics including the correlated risks of aging to...

InCarda at AF Symposium

January 24, 2019 - Boston, MA At the 2019 AF Symposium held in Boston, MA, Dr. Jeremy Ruskin presented an overview InCarda’s program of inhaled flecainide for treatment of Paroxysmal Atrial Fibrillation to several hundred clinicians in the audience.  Dr. Ruskin is Founder and Director of...

InCarda at Biotech Showcase 2019

January 8, 2019 - San Francisco, CA At 2019’s Biotech Showcase conference in San Francisco, InCarda’s Dr. Grace Colón was a guest panelist at the “Early Seed Alternative Financing” Workshop. In that discussion about early company financing, Dr. Colón advised attendees to talk with as many...

InCarda at San Francisco Business Times – Bay Area Biotech Forum

May 23, 2018 - San Francisco, CA At the SF Business Times Bay Area Biotech Forum, InCarda’s Dr. Grace Colon presented a company update to investors where she discussed the clinical challenges of Atrial Fibrillation and InCarda’s novel approach to treating it called, InRhythm (oral flecainide...